IDEAYA Biosciences, Inc.
Hedge Funds Holdings
Last updated:
IDEAYA Biosciences, Inc.‘s stocks are currently a part of 72 hedge funds’ portfolios, which represents 35.22% of the total amount of its stocks outstanding. This makes up a total of 14.59M shares of IDEAYA Biosciences, Inc.. Compared to the previous quarter, the number fell by -68.31% or -31.47M shares fewer. As for the holding position changes, 45.83% (33) of current hedge fund investors increased the number of shares held, 20.83% (15) of current holders sold a part of the shares held, and 8.33% (6) closed the holdings completely. 12 hedge funds are new holders of IDEAYA Biosciences, Inc. stock in Q1 2023, it is 16.67% of total holders.
Hedge funds holding IDEAYA Biosciences (Q2 2019 – Q1 2023)
Q2 2019 | 24 |
---|---|
Q3 2019 | 24 |
Q4 2019 | 29 |
Q1 2020 | 26 |
Q2 2020 | 64 |
Q3 2020 | 66 |
Q4 2020 | 82 |
Q1 2021 | 88 |
Q2 2021 | 83 |
Q3 2021 | 90 |
Q4 2021 | 109 |
Q1 2022 | 101 |
Q2 2022 | 96 |
Q3 2022 | 112 |
Q4 2022 | 118 |
Q1 2023 | 72 |
Hedge funds changes in IDEAYA Biosciences positions (Q2 2019 – Q1 2023)
Q2 2019 | 24 | 0 | 0 | 0 | 0 |
---|---|---|---|---|---|
Q3 2019 | 4 | 5 | 7 | 4 | 4 |
Q4 2019 | 12 | 3 | 6 | 7 | 1 |
Q1 2020 | 4 | 6 | 5 | 6 | 5 |
Q2 2020 | 42 | 15 | 3 | 4 | 0 |
Q3 2020 | 15 | 26 | 13 | 13 | -1 |
Q4 2020 | 24 | 29 | 13 | 8 | 8 |
Q1 2021 | 18 | 32 | 23 | 11 | 4 |
Q2 2021 | 7 | 43 | 16 | 12 | 5 |
Q3 2021 | 15 | 46 | 16 | 8 | 5 |
Q4 2021 | 26 | 48 | 23 | 7 | 5 |
Q1 2022 | 12 | 43 | 30 | 20 | -4 |
Q2 2022 | 11 | 28 | 37 | 15 | 5 |
Q3 2022 | 28 | 47 | 22 | 12 | 3 |
Q4 2022 | 18 | 56 | 27 | 11 | 6 |
Q1 2023 | 12 | 33 | 15 | 6 | 6 |
Hedge funds changes in IDEAYA Biosciences stock options (Q2 2019 – Q1 2023)
Q2 2019 | 0 | 0 |
---|---|---|
Q3 2019 | 0 | 0 |
Q4 2019 | 0 | 0 |
Q1 2020 | 0 | 0 |
Q2 2020 | 0 | 0 |
Q3 2020 | 0 | 0 |
Q4 2020 | 0 | 155,000 |
Q1 2021 | 524,000 | 428,000 |
Q2 2021 | 10,000 | 0 |
Q3 2021 | 1,389,000 | 0 |
Q4 2021 | 950,000 | 0 |
Q1 2022 | 1,485,000 | 0 |
Q2 2022 | 6,869,000 | 1,000 |
Q3 2022 | 7,114,000 | 1,000 |
Q4 2022 | 6,791,351 | 7,268 |
Q1 2023 | 5,000 | 0 |